AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Twelves, C Boyer, M Findlay, M Cassidy, J Weitzel, C Baker, C Osterwalder, B Jamieson, C Hieke, K
Citation: C. Twelves et al., Capecitabine (Xeloda (TM)) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients withadvanced colorectal carcinoma, EUR J CANC, 37(5), 2001, pp. 597-604

Authors: Van Cutsem, E Twelves, C Cassidy, J Allman, D Bajetta, E Boyer, M Bugat, R Findlay, M Frings, S Jahn, M McKendrick, J Osterwalder, B Perez-Manga, G Rosso, R Rougier, P Schmiegel, WH Seitz, JF Thompson, P Vieitez, JM Weitzel, C Harper, P
Citation: E. Van Cutsem et al., Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study, J CL ONCOL, 19(21), 2001, pp. 4097-4106

Authors: Dixon-Woods, M Findlay, M Young, B Cox, H Heney, D
Citation: M. Dixon-woods et al., Parents' accounts of obtaining a diagnosis of childhood cancer, LANCET, 357(9257), 2001, pp. 670-674

Authors: Findlay, M
Citation: M. Findlay, Juror comprehension and complexity - Strategies to enhance understanding, BR J CRIMIN, 41(1), 2001, pp. 56-76

Authors: Holbrook, A Findlay, M Misson, S
Citation: A. Holbrook et al., Using education indexes to map research trends, ONLINE INFO, 24(3), 2000, pp. 197-211

Authors: Barsan, N Stetter, JR Findlay, M Gopel, W
Citation: N. Barsan et al., High performance gas sensing of CO: comparative tests for (SnO2-based) semiconducting and for electrochemical sensors, SENS ACTU-B, 66(1-3), 2000, pp. 31-33

Authors: Tan, CK Chow, PK Findlay, M Wong, C Machin, D
Citation: Ck. Tan et al., Use of tamoxifen in hepatocellular carcinoma: A review and paradigm shift, J GASTR HEP, 15(7), 2000, pp. 725-729

Authors: Van Cutsem, E Findlay, M Osterwalder, B Kocha, W Dalley, D Pazdur, R Cassidy, J Dirix, L Twelves, C Allman, D Seitz, JF Scholmerich, J Burger, HU Verweij, J
Citation: E. Van Cutsem et al., Capecitabine, an oral fluoropyrimidine carbamate with substantial activityin advanced colorectal cancer: Results of a randomized phase II study, J CL ONCOL, 18(6), 2000, pp. 1337-1345

Authors: Dodds, HM Clarke, SJ Findlay, M Bishop, JF Robert, J Rivory, LP
Citation: Hm. Dodds et al., Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance, CANC CHEMOT, 45(1), 2000, pp. 9-14

Authors: Clarke, K Basser, RL Underhill, C Mitchell, P Bartlett, J Cher, L Findlay, M Dalley, D Pell, M Byrne, M Geldard, H Hill, JS Maher, D Fox, RM Green, MD Kaye, AH
Citation: K. Clarke et al., KRN8602 (MX2-hydrochloride): An active new agent for the treatment of recurrent high-grade glioma, J CL ONCOL, 17(8), 1999, pp. 2579-2584

Authors: Barsan, N Stetter, JR Findlay, M Gopel, W
Citation: N. Barsan et al., High performance gas sensing of CO: Comparative tests for semiconducting (SnO2-based) and for amperometric gas sensors, ANALYT CHEM, 71(13), 1999, pp. 2512-2517

Authors: MacLeod, C Palmer, A Findlay, M
Citation: C. Macleod et al., Primary non-Hodgkin's lymphoma of the vulva: A case report, INT J GYN C, 8(6), 1998, pp. 504-508
Risultati: 1-12 |